Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Neurochem. 2011 Nov 1;119(5):1074–1085. doi: 10.1111/j.1471-4159.2011.07513.x

Table 1.

Neuropeptides identified from wild type mice spinal cord by MS/MS.

Precursor Peptide
name
Peptide sequence Obs.
Mass
Theor.
Mass
Error
(ppm)
PEAKS
Score
LC-ESI-IT LC-ESI-Q-
TOF
Procholecystokinin 23–32 *QP.WPAEATDPV.E 996.82 996.51 311 78 X
Proenkephalin Met-enkephalin KK.YGGFM.KR 573.4 573.23 296 54 X
Proenkephalin 197–208 KR.SPQLEDEAKELQ.KR 1385.99 1385.67 231 99 X
ProSAAS little SAAS R.SLSAASAPLVETSTPLRL.RR 1812.66 1812.0 364 99 X
ProSAAS PEN RR.SVDQDLGPEVPPENVLGALLRV.KR 2316.84 2316.23 263 99 X
Prosomatostatin Somatostatin 28–14 R.SANSNPAMAPRE.RK 1243.79 1243.56 185 98 X
Protachykinin A Neurokinin A KR.HKTDSFVGL(AmideM).GKR 1132.54 1132.57 26 45 X
Protachykinin B Neurokinin B KR.DMHDFFVGLMa.GKR 1209.61 1209.52 74 97 X
Secretogranin 1 588–597 KR.SFARAPQLDL.KR 1117.01 1116.59 376 86 X
Secretogranin II 569–581 KR.IPVGSLKNEDTPN.R 1382.59 1382.7 80 80 X X

(.) indicates a cleavage site;

(*)

indicates the presence of signal peptide before the sequence;

“X” indicates the MS/MS platforms used to identify the peptide; Obs. mass, observed monoisotopic mass; Theor. mass, theoretical monoisotopic mass; putative PTM includes C-terminal amidation (“Amide”).